What is Perrigo?
Founded in 1887, Perrigo has evolved into a preeminent global healthcare supplier, specializing in the development and manufacturing of high-quality private label pharmaceuticals. The company operates at the intersection of consumer health and pharmaceutical manufacturing, providing essential products that empower patients to manage their health effectively. With a deep-rooted commitment to accessibility and affordability, Perrigo maintains a dominant footprint in the OTC space, serving as a critical partner for retailers and healthcare providers worldwide. Its business model is characterized by a sophisticated supply chain and a diverse portfolio that addresses a wide spectrum of consumer wellness needs, ensuring consistent demand across global markets.
How much funding has Perrigo raised?
Perrigo has raised a total of $1B across 1 funding round:
Stock Offering
$1B
Stock Issuance/Offering (2014): $1B, investors not publicly disclosed
Key Investors in Perrigo
Perrigo
Undisclosed investor participating in the funding round.
What's next for Perrigo?
Looking ahead, the infusion of capital is expected to catalyze Perrigo's strategic initiatives, particularly in the realms of product innovation and market penetration. As the healthcare industry shifts toward more personalized and accessible care, Perrigo is well-positioned to leverage its manufacturing prowess to capture emerging opportunities in the OTC segment. The company's focus will likely remain on optimizing its operational efficiency and expanding its reach within international markets, ensuring that it remains a preferred partner for private label solutions. By prioritizing research and development alongside strategic acquisitions, Perrigo aims to sustain its growth momentum and reinforce its status as a leader in the global healthcare supply chain, navigating the complexities of modern pharmaceutical regulation with agility and foresight.
See full Perrigo company page
